Cointime

Biofidelity

company

About

Biofidelity developed a revolutionary molecular diagnostics.

  • 11 - 50

Highlights

Total Funding Amount
$23M
Funding Rounds
1
Investors
1
Investments
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$23M
Industries
Biotechnology,Genetics,Health Care
Founded date
Feb 15, 2019
Number Of Employee
11 - 50
Operating Status
Active

Biofidelity developed a revolutionary molecular diagnostic assay that enables the rapid detection of target DNA sequences. Biofidelity’s mission is to improve and extend patients’ lives by enabling early detection of disease and better targeting of treatments with applications spanning oncology, prenatal testing, infectious disease, and organ transplant monitoring.

Biofidelity was founded in 2019 and is headquartered of Cambridge, England.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$23M
Biofidelity has raised a total of $23M in funding over 2 rounds. Their latest funding was raised on Feb 1, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Feb 1, 2022 Series A $23M 1 Octopus Ventures — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Biofidelity has made 1 investments. Their most recent investment was on May 19, 2011, when Domo raised $10M.
Date Company Name
Round Money Raised Industry Lead Investor
May 19, 2011 Domo
Angel $10M Business Intelligence —

Investors

Number of Lead Investors
Number of Investors
1
1
Biofidelity is funded by 1 investors. Octopus Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Octopus Ventures Yes Series A
Cointime
Содержание
компания